1. Field of the Invention
The present invention relates generally to medical methods and apparatus and more particularly to the delivery and manipulation of stents and other prostheses in the vascular system.
Balloon dilatation (angioplasty) is a common medical procedure mainly directed at revascularization of stenotic vessels by inserting a catheter having a dilatation balloon through the vascular system. The balloon is inflated inside a stenosed region in a blood vessel in order to apply radial pressure to the inner wall of the vessel and widen the stenosed region to enable better blood flow.
In many cases, the balloon dilatation procedure is immediately followed by a stenting procedure where a stent is placed to maintain vessel patency following the angioplasty. Failure of the angioplasty balloon to properly widen the stenotic vessel, however, may result in improper positioning of the stent in the blood vessel. If a drug-eluting stent is used, its effectiveness may be impaired by such improper positioning and the resulting restenosis rate may be higher. This is a result of several factors, including the presence of gaps between the stent and the vessel wall, calcified areas that were not treated properly by the balloon, and others.
Stent placement can be particularly difficult when the plaque material is hard, fibrotic, or calcified and interferes with the uniformity of stent expansion. Balloon inflation of the stent occurs preferentially in the softer or least resistant areas of the stenotic material. Using high balloon inflation pressure to expand the stent in the more resistant regions can often cause stretching and damage to the vessel wall in the regions of softer stenotic material.
Stent placement is also problematic when the treated region is at a blood vessel bifurcation. When a stent is placed in a main vessel, the opening to a side branch can be covered or “jailed” by the stent struts. Such interference with the opening to the side branch is particularly troublesome when it is necessary to enter the side branch for further treatment. In such cases, a balloon catheter is typically used to open a cell in the stent to minimize interference.
The use of conventional angioplasty balloons to open “holes” in the side of a stent can be quite difficult. If the stent struts are broken, they may damage the blood vessel wall and/or the balloon. When a conventional angioplasty balloon is used to open a cell of a stent, the balloon will first expand at the distal and the proximal areas of the balloon. Expansion of the center of the balloon will usually be constrained by the cell until the cell resistance is abruptly overcome. The cell will then rapidly expand in an uncontrolled manner when the internal pressure overcomes the cell resistance. Even when the stent remains intact, opening of the cell can be non-uniform, leaving an irregular passage for subsequent introduction of the angioplasty catheter needed to treat the side branch.
For these reasons, it would be desirable to provide improved balloon and other catheters for the delivery and manipulation of stents and other vascular prostheses. In particular, it would be desirable to provide delivery methods and apparatus which are capable of delivering and opening a prosthesis in a highly uniform manner, regardless of the degree of calcification which may be present in the plaque or other stenotic material being treated. It would be further desirable to provide stent delivery structures which are able to uniformly apply relatively large expansion forces to the interior of the stent or other prostheses being opened. It would still further be desirable to provide improved methods and apparatus for opening passages in the stent or other prosthesis after it has been delivered. Such apparatus and methods should provide for uniform and effective opening of the interior of a cell of the stent, particularly to provide passage into a side branch vessel covered by the stent. At least some of these objectives will be met by the inventions described hereinafter.
2. Description of the Background Art
U.S. Pat. No. 6,129,706 and U.S. Published Application 2003/0032973 describe balloons having spiral or other surface structures which may be used for delivering prostheses. U.S. Pat. No. 6,245,040 and U.S. Published Applications 2003/0153870 and 2004/0111108 describe structures placed over dilatation balloons for various purposes including perfusion, anti-slip, and plaque cutting. Other modified balloon structures having helical geometrics are described in U.S. Pat. Nos. 5,545,132 and 5,735,816; and U.S. Published Application 2003/0144683. U.S. Pat. No. 6,447,501 describes a stent delivery system with a guidewire extending over the stent expansion balloon.
The present invention provides improved methods and apparatus for the delivery and manipulation of stents and other prostheses in the vasculature and other body lumens. In a first aspect, the present invention is particularly intended for the delivery of vascular prostheses within regions of fibrotic, calcified, or otherwise hardened plaque or other stenotic material of the type which can interfere with stent expansion using conventional angioplasty balloons. In a second particular aspect, the present invention will be useful for opening passages through the wall of a previously implanted stent or other vascular prosthesis. Usually, the opening will be into a branch vessel through a prosthesis in the main vessel which at least partly covers or blocks the opening or os to the branch vessel. The methods and apparatus will find their greatest use in the treatment of the arterial vasculature, including but not limited to the coronary arterial vasculature, but may also find use in the treatment of the venous and/or peripheral vasculature, and in the delivery of other prostheses to other body lumens outside of the vasculature.
In a first aspect of the present invention, a method for expanding a vascular prosthesis within a region of hardened plaque comprises delivering a prosthesis to the region of hardened plaque. A shell is then expanded within the prosthesis to cause expansion, where the shell is disposed within an interface structure which engages an inner surface of the prosthesis as it is expanded. The interface surface is adapted to engage the inner surface of the prosthesis without causing damage and in a manner which provides a number of expansion points to promote uniform expansion of the prosthesis.
According to the second aspect of the present invention, a passage through the wall of the prosthesis in a main vessel is opened by positioning an expansible shell, typically an inflatable balloon, through a cell in the prosthesis. An interface structure surrounds the expansible shell, and the interface structure engages the periphery of the cell as the shell is expanded within the cell to open the cell.
As is well known in the art, stents and other vascular prostheses include expansible cells which expand when the prosthesis is radially opened within the target blood vessel. The cells may be “open” or “closed”. Open cells are characteristic of conventional serpentine and zig-zagged stent structures. Closed cells, in contrast, are characterized by relatively small, closed rectangular, diamond, or other structures with a closed periphery. The present invention will be suitable for expanding an open region or a passage through either type of cell by expanding the shell therein. Particularly, by providing the interface structure, the balloon can apply relatively uniform or equal forces at a number of points on the shell in order to promote uniform opening and limit possible damage to the balloon or other shell from the stent.
Both aspects of the method of the present invention may employ a similar interface structure which comprises a plurality of interface elements each having an outwardly exposed surface which engages either the inner surface of the prosthesis or an inner circumference of a cell of the prosthesis. The outwardly exposed surface is preferably free from scoring features (in contrast to the earlier applications of the assignee of the present application) which could damage the prosthesis. For example, the outwardly exposed surfaces may be flattened and have rounded corners. The flattened surface will provide an efficient transfer of outward force, while the rounded corners will prevent scoring or damage to the stent or other prosthesis. Usually, the interface structure will comprise a plurality of such interface elements, and the interface elements will be arranged helically over the expansion balloon or other expansible shell. Usually, the interface structure will be elastic, e.g. being composed from a superelastic material, so that it will close the shell after expansion is completed.
The present invention still further provides a stent manipulation catheter which is useful for performing these methods. The stent manipulation catheter comprises a catheter body having a proximal end and a distal end. A radially expansible shell is disposed near the distal end of the catheter body, and the interface structure circumscribes but is not attached to the shell. Usually, the interface structure comprises at least one continuous interface element extending over the entire length of the shell, typically being arranged helically over the shell. The interface structure will usually comprise two, three, four or more individual interface elements, typically all being arranged helically. The total exposed area of the shell, however, will be below 20% of the expansible area of the shell, preferably being below 10%, and usually being below 5%. In the exemplary cases, the interface structure may comprise a wire, a chemically etched strut, or the like.
The interface structure is preferably incorporated into a cage structure which circumscribes the expansible shell. The cage structure is preferably unattached to the expansible shell but usually attached at at least one point to the catheter body. In a specific embodiment, the cage structure is attached to the catheter body by an attachment structure having a proximal end attached to the catheter body and a distal end attached to the cage structure. The attachment structure is sufficiently sized and compliant to accommodate geometrical and reaction forces produced by the cage structure as it is expanded by the shell. Further preferably, the assembly of the shell and the interface structure will be sufficiently flexible to permit it to bend at a radius of 10 mm or less as the catheter is advanced through the coronary or other vasculature.
Referring now to
The interface structure 252 is illustrated as three separate helical interface elements, typically composed of nitinol or other superelastic material. While this is a presently preferred geometry, it will be appreciated that the number of interface elements may vary from one to ten or even greater. Moreover, while the helical geometry is preferred, it is not essential and the interface elements could be straight, serpentine, zig-zag, or have any one of a variety of other configurations which permit expansion of the balloon therein. The helical structure is generally preferred, however, since it reduces the risk of the elements interfering with the stent structure as the balloon is used to expand a stent or other prosthesis and/or pass through a cell of the stent structure in order to permit subsequent expansion.
Attachment structure 258 typically comprises a cylindrical over-tube, or compliance tube, made of an elastic material. Over-tube 258 generally has an inner diameter that is slightly greater than the outer diameter of the catheter body 256. Because only a small section of the proximal end of the attachment structure 258 is fixed to the catheter body, the distal end 264 attached to interface structure 252 is free floating, and is free to slide axially and rotationally with respect to catheter body 256. Attachment structure 252 may be fixed, for example by adhesion, directly to the to catheter body 256 and external structure 252, or to a collar or other intermediate attachment means.
As balloon 254 is expanded, interface structure 252 expands in circumference and contracts axially along the catheter body 256, creating axial force in the direction of arrow A on attachment structure 258. Attachment structure 258, fixed to the catheter at its end 266, axially stretches to accommodate the axial movement of the interface structure 252. Interface structure 252 also tends to rotate about the catheter body 256, causing a torsional force T. The distal end 264 of attachment structure 258 rotates through the full range of motion of scoring structure 252 to accommodate torsional force T, while proximal end 266 remains stationary with respect to catheter body 256.
The configuration illustrated in
The compliance of the system may be varied by any combination of material selection, wall thickness, or length of the over-tube 258. Over-tube 258 may comprise any elastomer, such as elastic polymer like Nylon, Pebax, or PET. Typically, compliance tube 258 is formed from extruded tubing, but is may also comprise braided polymeric or metallic fibers, or wire mesh. A superelastic metal such as nitinol or stainless steel may also be used. Where the compliance tube comprises an extruded polymeric tube, the wall thickness can vary in the ranges set forth above, and the length of the tube can range from 1 cm to 10 cm. For the same material, the thinner-walled and longer the tube, the more compliant the system.
Referring to
Referring to
The taper may run across the whole length of the compliance tube, or alternatively be only tapered at a section of the length of the compliance tube. The tapered compliance tube 258 smoothes the transition between the scoring structure and catheter body, and minimizes the likelihood of the outer tube or scoring structure snagging or catching on a portion of the luminal wall during delivery or retrieval of the catheter.
Now referring to
In some embodiments, the compliance of the interface structure 252 and balloon 254 is controlled by actuating the manipulator during expansion or contraction of the radially expandable shell. In one aspect, the attachment structure 258 may be axially advanced with respect to the catheter body 256 as the balloon is being inflated or deflated. For example, the attachment structure 258 may be pulled away from the distal end of the catheter body 256 while the balloon 254 is being expanded to constrain the compliance of balloon. The attachment structure 258 may also be pulled away from the distal end of the catheter body 256 during or after the balloon 254 is being deflated to minimize the profile of the balloon and scoring structure. Alternatively, the manipulator 360 may be used to rotate the attachment structure 258 with respect to the catheter body 256 to control the compliance of the balloon and scoring structure during transition from a collapsed to expanded state and back to a collapsed state.
Now referring to
The laminating structure may be composed of a polymer similar to the compliance tube 402, and may be heat shrunk or melted to thermally bond the compliance sleeve to the compliance tube and sandwich the interface elements 406. Alternatively, an adhesive or other bonding method such as ultrasonic or RF energy may be used to laminate the structure. The laminated structure as shown in
The interface elements 406 are shown to have a generally square or rectangular cross section. For example, the elements 406 may have a rectangular cross section as shown in
Now referring to FIGS. 10 to 12, a method is illustrated for mounting an expandable interface cage 406 over a balloon catheter. The interface cage 406 is pre-expanded by loading it over an insertion tube 422 that has an inner diameter slightly larger than the outer diameter of the balloon 412. A catheter body 420 having a balloon 412 is then inserted into the inner diameter of the insertion tube 422 and advanced until the balloon 412 is appropriately positioned with respect to the interface structure 406, as illustrated in
Referring now to
Referring now to
Referring now to
Using the balloon or other expandable shell expandable shell with the interface structure to deliver stents enables the transmission of larger forces to the lesion through stent to the surrounding vessel wall and enhances better wall apposition of the stent even in hard lesions. In many cases stents have poor wall apposition in lesions with non uniform calcification. In those lesions the balloon yields at the calcified segments and the stent does not fully deploy in such segments. By using the interface surface of the present invention, the balloon or other expandable shell uniformly distributes the outward forces and supports the stent during expansion and allows full dilatation even in calcified segments. This advantage is even more important with thin wall stents which individual cells with lower radial force since the struts are very thin in comparison to conventional stents. The use of the interface structures of the present invention should in at least some instances reduce or eliminate the need for pre dilatation.
Additionally, when the balloon is deflated after the stent has been deployed, the interface structure helps deflate the balloon by applying an inward radial force which helps prevent the balloon from “winging.” Winging occurs when the balloon deflates to a flat shape. The flat balloons is very narrow in one axis but wider than the vessel in the other axis. The balloon can thus have a tendency to get caught by a stent strut or rub against the vessel wall, making the balloon retrieval difficult. At worst, balloon capture by a stent strut can cause a failure of the procedure enhanced by the interface surface can result in a low profile deflated balloon which is easier to remove.
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Alternate embodiments are contemplated that fall within the scope of the invention.
This application is a continuation-in-part of commonly assigned, co-pending U.S. application Ser. No. 10/810,330, filed on Mar. 25, 2004 (Attorney Docket No. 021770-000120US), which is a continuation-in-part of U.S. application Ser. No. 10/631,499, filed on Jul. 30, 2003 (Attorney Docket No. 021770-00010US), which claims the benefit under 35 USC §119(e) of U.S. Provisional Application No. 60/442,161, filed on Jan. 21, 2003 (Attorney Docket No. 021770-000100US), the full disclosures of which are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
60442161 | Jan 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10810330 | Mar 2004 | US |
Child | 10917902 | Aug 2004 | US |
Parent | 10631499 | Jul 2003 | US |
Child | 10810330 | Mar 2004 | US |